01555nam 2200397Ia 450 991069885460332120090514150030.0(CKB)5470000002397319(OCoLC)320964305(EXLCZ)99547000000239731920090514d2006 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] characterization and qualification of cell substrates and other biological starting materials used in the production of viral vaccines for the prevention and treatment of infectious diseasesRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2006]ii, 49 pages digital, PDF fileTitle from PDF title page (viewed on May 14, 2009)."September, 2006".Includes bibliographical references (pages 44-46).Guidance for industry BiologicalsUnited StatesViral vaccinesUnited StatesCommunicable diseasesUnited StatesPreventionBiologicalsViral vaccinesCommunicable diseasesPrevention.Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698854603321Guidance for industry3434577UNINA